China Healthwise Holdings Limited (0348.HK)
HKD 0.1
(6.45%)
HKD 0.1
(6.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 146.31 Million HKD | 3.0% |
| 2022 | 142.05 Million HKD | -16.48% |
| 2021 | 170.07 Million HKD | 23.38% |
| 2020 | 137.85 Million HKD | -4.19% |
| 2019 | 143.87 Million HKD | -68.14% |
| 2018 | 451.61 Million HKD | -33.83% |
| 2017 | 682.54 Million HKD | 113.82% |
| 2016 | 319.22 Million HKD | -9.52% |
| 2015 | 352.79 Million HKD | -9.41% |
| 2014 | 389.42 Million HKD | 101.08% |
| 2013 | 193.66 Million HKD | -7.49% |
| 2012 | 209.34 Million HKD | -50.13% |
| 2011 | 419.75 Million HKD | -21.98% |
| 2010 | 538.03 Million HKD | 33.71% |
| 2009 | 402.4 Million HKD | -36.85% |
| 2008 | 637.22 Million HKD | -20.26% |
| 2007 | 799.14 Million HKD | 13.38% |
| 2006 | 704.81 Million HKD | -6.1% |
| 2005 | 750.62 Million HKD | -3.11% |
| 2004 | 774.71 Million HKD | 4.14% |
| 2003 | 743.91 Million HKD | 3.8% |
| 2002 | 716.71 Million HKD | 9.02% |
| 2001 | 657.43 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 30.46 Million HKD | -53.48% |
| 2024 Q2 | 30.46 Million HKD | 0.0% |
| 2023 Q3 | 32.74 Million HKD | -59.49% |
| 2023 FY | 146.31 Million HKD | 3.0% |
| 2023 Q1 | 40.41 Million HKD | -38.57% |
| 2023 Q2 | 80.82 Million HKD | 100.0% |
| 2023 Q4 | 65.49 Million HKD | 100.0% |
| 2022 Q2 | 76.27 Million HKD | 100.0% |
| 2022 Q3 | 32.89 Million HKD | -56.87% |
| 2022 FY | 142.05 Million HKD | -16.48% |
| 2022 Q1 | 38.13 Million HKD | -47.17% |
| 2022 Q4 | 65.78 Million HKD | 100.0% |
| 2021 Q4 | 72.18 Million HKD | 100.0% |
| 2021 FY | 170.07 Million HKD | 23.38% |
| 2021 Q1 | 48.94 Million HKD | 144.56% |
| 2021 Q2 | 97.89 Million HKD | 100.0% |
| 2021 Q3 | 36.09 Million HKD | -63.13% |
| 2020 Q2 | 117.83 Million HKD | 221.97% |
| 2020 Q4 | 20.01 Million HKD | 0.0% |
| 2020 Q1 | 36.59 Million HKD | 0.0% |
| 2020 FY | 137.85 Million HKD | -4.19% |
| 2019 FY | 143.87 Million HKD | -68.14% |
| 2019 Q1 | 96.2 Million HKD | 0.0% |
| 2018 Q3 | 305.63 Million HKD | 135.82% |
| 2018 Q1 | 57.64 Million HKD | -67.8% |
| 2018 FY | 451.61 Million HKD | -33.83% |
| 2018 Q2 | 129.6 Million HKD | 124.83% |
| 2017 Q4 | 179 Million HKD | 10.31% |
| 2017 FY | 682.54 Million HKD | 113.82% |
| 2017 Q2 | 162.26 Million HKD | 143.05% |
| 2017 Q1 | 66.76 Million HKD | 0.0% |
| 2017 Q3 | 162.26 Million HKD | 0.0% |
| 2016 Q3 | 92.84 Million HKD | 0.0% |
| 2016 Q1 | 82.86 Million HKD | 0.0% |
| 2016 Q4 | 66.76 Million HKD | -28.09% |
| 2016 Q2 | 92.84 Million HKD | 12.05% |
| 2016 FY | 319.22 Million HKD | -9.52% |
| 2015 Q2 | 93.53 Million HKD | 14.91% |
| 2015 Q3 | 93.53 Million HKD | 0.0% |
| 2015 Q4 | 82.86 Million HKD | -11.41% |
| 2015 Q1 | 81.4 Million HKD | 0.0% |
| 2015 FY | 352.79 Million HKD | -9.41% |
| 2014 Q4 | 81.4 Million HKD | -28.16% |
| 2014 Q2 | 113.31 Million HKD | 200.04% |
| 2014 Q3 | 113.31 Million HKD | 0.0% |
| 2014 FY | 389.42 Million HKD | 101.08% |
| 2014 Q1 | 37.76 Million HKD | 0.0% |
| 2013 Q2 | 59.06 Million HKD | 85.96% |
| 2013 Q4 | 37.76 Million HKD | -36.06% |
| 2013 Q1 | 31.76 Million HKD | 0.0% |
| 2013 Q3 | 59.06 Million HKD | 0.0% |
| 2013 FY | 193.66 Million HKD | -7.49% |
| 2012 Q3 | 72.9 Million HKD | 0.0% |
| 2012 FY | 209.34 Million HKD | -50.13% |
| 2012 Q4 | 31.76 Million HKD | -56.43% |
| 2012 Q1 | 51.39 Million HKD | 0.0% |
| 2012 Q2 | 72.9 Million HKD | 41.87% |
| 2011 Q3 | - HKD | 0.0% |
| 2011 Q4 | 51.39 Million HKD | 0.0% |
| 2011 Q1 | - HKD | 0.0% |
| 2011 FY | 419.75 Million HKD | -21.98% |
| 2010 Q1 | - HKD | 0.0% |
| 2010 FY | 538.03 Million HKD | 33.71% |
| 2010 Q3 | - HKD | 0.0% |
| 2009 Q1 | - HKD | 0.0% |
| 2009 FY | 402.4 Million HKD | -36.85% |
| 2008 FY | 637.22 Million HKD | -20.26% |
| 2007 FY | 799.14 Million HKD | 13.38% |
| 2006 FY | 704.81 Million HKD | -6.1% |
| 2005 FY | 750.62 Million HKD | -3.11% |
| 2004 FY | 774.71 Million HKD | 4.14% |
| 2003 FY | 743.91 Million HKD | 3.8% |
| 2002 FY | 716.71 Million HKD | 9.02% |
| 2001 FY | 657.43 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Tycoon Group Holdings Limited | 1.19 Billion HKD | 87.793% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.52 Billion HKD | 90.405% |